addenda

1
Addenda The author wishes to correct the following errors made by the author in her article: Foens C. Opinion: Emerging Technologies in Radiation Oncology and Nuclear Medicine: An Overview of Their Use and Regulation. J Am Coll Radiol 2004;1:619 –23: Sodium phosphate used intravenously in the management of polycythemia vera is a solution, not a colloid. With respect to the drug, Bexxar, I-131 (not I-125) is linked to Tositumomab. Wallner PE. Heard on the campus: We’re from the government and are here to help you. Really! J Am Coll Radiol 2004;1:310, listed the contact for the Interagency Council on Biomedical Imaging in Oncology as Jaime Kenyon. Ms. Kenyon has left the NCI. The new contact is Teresa R. Zuber, MA, Interagency Council on Biomedical Imaging in Oncology, 6130 Executive Boulevard, EPN 6071B, Rockville, MD 20852-7412; telephone: (301) 435-4490; fax: (301) 480-3507; e-mail: [email protected]. 1001

Upload: trinhkiet

Post on 03-Jan-2017

212 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Addenda

1001

AddendaThe author wishes to correct the following errors made by the author in her article: Foens C. Opinion:Emerging Technologies in Radiation Oncology and Nuclear Medicine: An Overview of Their Use andRegulation. J Am Coll Radiol 2004;1:619–23: Sodium phosphate used intravenously in the managementof polycythemia vera is a solution, not a colloid.

With respect to the drug, Bexxar, I-131 (not I-125) is linked to Tositumomab.

Wallner PE. Heard on the campus: We’re from the government and are here to help you. Really! J Am CollRadiol 2004;1:310, listed the contact for the Interagency Council on Biomedical Imaging in Oncology asJaime Kenyon. Ms. Kenyon has left the NCI. The new contact is Teresa R. Zuber, MA, InteragencyCouncil on Biomedical Imaging in Oncology, 6130 Executive Boulevard, EPN 6071B, Rockville, MD20852-7412; telephone: (301) 435-4490; fax: (301) 480-3507; e-mail: [email protected].